Mortality prediction in chronic interstitial lung diseases (ILDs): ILD-GAP (gender age physiology) and (the new modified classification) TNMC-ILD-GAP

1. Ryerson C, Vittinghoff E, Ley B, Lee J, Mooney J, Jones K, et al. Predicting survival across chronic interstitial lung disease. Chest. 2014;145: 723–728.10.1378/chest.13-147424114524Search in Google Scholar

2. Park JH, Kim DS, Park I-N, Jang SJ, Kitaichi M, Nicholson AG, et al. Prognosis of fibrotic interstitial pneumonia. American Journal of Respiratory and Critical Care Medicine. 2007;175: 705–711.10.1164/rccm.200607-912OC17218621Search in Google Scholar

3. Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Annals of Internal Medicine. 2012;156: 684–691.10.7326/0003-4819-156-10-201205150-0000422586007Search in Google Scholar

4. Mura M, Porretta MA, Bargagli E, Sergiacomi G, Zompatori M, Sverzellati N, et al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study. European Respiratory Journal. 2012;40: 101–109.10.1183/09031936.0010601122241745Search in Google Scholar

5. Bois RMD, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine. 2011;184: 459–466.10.1164/rccm.201011-1790OC21616999Search in Google Scholar

6. Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine 2000;161: 487–492.10.1164/ajrccm.161.2.990601510673190Search in Google Scholar

7. Caminati A, Bianchi A, Cassandro R, Mirenda MR, Harari S. Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respiratory Medicine. 2009;103: 117–123.10.1016/j.rmed.2008.07.02218786822Search in Google Scholar

8. Celli BR, Cote CG, Marin JM, Casanova C, MM de Oca, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. The New England Journal of Medicine. 2004;350: 1005–1012.10.1056/NEJMoa02132214999112Search in Google Scholar

9. Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, et al. An official american thoracic society/european respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. American Journal of Respiratory and Critical Care Medicine. 2013;188: 733–748.10.1164/rccm.201308-1483ST580365524032382Search in Google Scholar

10. Bendstrup E, Maher T, Manali E, Wijsenbeek M. Challenges in the classification of fibrotic ILD. Sarcoidosis Vasculitis and Diffuse Lung Disease 2015;32(Suppl 1): 4–9.Search in Google Scholar

11. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE Jr., et al; IPF Study Group. The clinical course of patients with idiopathic pulmonary fibrosis. Annals of Internal Medicine. 2005;142: 963–967.10.7326/0003-4819-142-12_Part_1-200506210-00005Search in Google Scholar

12. Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2021. Available from: https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf.Search in Google Scholar

13. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. Updated 2021. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf.Search in Google Scholar

14. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al; International Association for the Study of Lung Cancer International Staging Committee. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. Journal of Thoracic Oncology. 2007;2: 706–714.10.1097/JTO.0b013e31812f3c1a17762336Search in Google Scholar

15. Low S. Using the ILD-GAP model to predict mortality in chronic interstitial lung disease. European Respiratory Journal. 2015;46(Suppl 59): PA3824. doi: 10.1183/13993003.congress-2015.PA3824.10.1183/13993003.congress-2015.PA3824Search in Google Scholar

16. Ley B, Collard HR, TE King Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 2011;183: 431–440.10.1164/rccm.201006-0894CI20935110Search in Google Scholar

17. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique-1995 update. American Journal of Respiratory and Critical Care Medicine. 1995;152: 2185–2198.10.1164/ajrccm.152.6.85207968520796Search in Google Scholar

18. Jensen RL, Carpo RO. Diffusion capacity: how to get it right. Respiratory Care. 2003;48: 777–782.Search in Google Scholar

19. Lederer DJ, Arcasoy SM, Wilt JS, D’ovidio F, Sonett JR, Kawut SM. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine. 2006;174: 659–664.10.1164/rccm.200604-520OC264805716778159Search in Google Scholar

20. Nathan SD, Basavaraj A, Reichner C, Shlobin OA, Ahmad S, Kiernan J, et al. Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. Respiratory Medicine. 2010;104: 1035–1041.10.1016/j.rmed.2010.02.00820199856Search in Google Scholar

21. Behr J, Ryu J. Pulmonary hypertension in interstitial lung disease. European Respiratory Journal. 2008;31: 1357–1367.10.1183/09031936.0017130718515559Search in Google Scholar

22. Corte TJ, Wort SJ, Talbot S, Macdonald PM, Hansell DM, Polkey M. et al. Elevated nocturnal desaturation index predicts mortality in interstitial lung disease. Sarcoidosis Vasculitis and Diffuse Lung Diseases. 2012;29: 41–50.Search in Google Scholar

23. du Bois R, Albera C, Bradford W, Costabel U, Leff J, Noble P, et al. 6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. European Respiratory Journal. 2013;43: 1421–1429.10.1183/09031936.0013181324311766Search in Google Scholar